Search research articles
Contact Us
Filters
Showing results (551-560 of 576) with videos related to
Page
of 58
Sort By:
European Urology Focus
|
July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer
|
March 15, 2018
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
Darren R Feldman, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, et al.
Journal of Clinical Epidemiology
|
October 20, 2018
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
Leila Rooshenas, Lauren J Scott, Jane M Blazeby, et al.
Urologic Oncology
|
May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer
Brandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Geriatric Oncology
|
May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer
Brandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy
Chunkit Fung, Howard D Sesso, Annalynn M Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2017
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
M Eileen Dolan, Omar El Charif, Heather E Wheeler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 13, 2025
Shear Stress Targeted Delivery of Nitroglycerin to Brain Collaterals Improves Ischaemic Stroke Outcome
Magdalena Litman, Sara Azarpeykan, Rebecca J Hood, et al.
Nature Medicine
|
January 19, 2024
The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring
Hani J Marcus, Pedro T Ramirez, Danyal Z Khan, et al.
Nature Medicine
|
January 31, 2024
Author Correction: The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring
Hani J Marcus, Pedro T Ramirez, Danyal Z Khan, et al.
Page
of 58
Search research articles
Search
Showing results (551-560 of 576) with videos related to
Sort By:
Page
of 58
European Urology Focus
|
July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer
David D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer
|
March 15, 2018
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
Darren R Feldman, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, et al.
Journal of Clinical Epidemiology
|
October 20, 2018
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
Leila Rooshenas, Lauren J Scott, Jane M Blazeby, et al.
Urologic Oncology
|
May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer
Brandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Geriatric Oncology
|
May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer
Brandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy
Chunkit Fung, Howard D Sesso, Annalynn M Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2017
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
M Eileen Dolan, Omar El Charif, Heather E Wheeler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 13, 2025
Shear Stress Targeted Delivery of Nitroglycerin to Brain Collaterals Improves Ischaemic Stroke Outcome
Magdalena Litman, Sara Azarpeykan, Rebecca J Hood, et al.
Nature Medicine
|
January 19, 2024
The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring
Hani J Marcus, Pedro T Ramirez, Danyal Z Khan, et al.
Nature Medicine
|
January 31, 2024
Author Correction: The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring
Hani J Marcus, Pedro T Ramirez, Danyal Z Khan, et al.
Page
of 58